Tuesday, 23 September 2025 (17:00-19:00 CEST, SPAAK 7C50)
European Parliament, Brussels
Co-hosted and co-organised by:
MEP Vlad Voiculescu (RE, Romania) & Romana Jerkovic (S&D, Croatia)
With the participation of the European Society for Paediatric Oncology (SIOPE) and Childhood Cancer International - Europe (CCI-E)
Check Out the Programme!
Register Here
The European Society for Paediatric Oncology (SIOPE) and Childhood Cancer International - Europe (CCI-E) invite you to participate in this key event dedicated to raising awareness about paediatric cancers in Europe and advocating for continued and increased EU funding for childhood cancers in the next Multiannual Financial Framework (MFF). The MFF is the EU’s long-term budget that sets expenditure priorities for a seven-year period, shaping investments in critical areas such as healthcare and research.
The current MFF (2021–2027) has supported paediatric oncology through EU4Health and Horizon Europe, driving progress in care, research, and innovation. Initiatives like Europe’s Beating Cancer Plan and the EU Cancer Mission further show the EU’s commitment. However, challenges in implementation remain. To significantly address these issues, it is imperative that the unmet needs of childhood cancer patients and survivors remain a priority for the EU, emphasizing the need for continued funding in the next MFF.
This event will explore both the successes and the gaps in the implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission. The discussion will focus on how these gaps must be addressed in the next MFF to ensure progress. By bringing together policymakers, researchers, healthcare professionals, and patient advocates, the event will underline the critical role of EU support in ensuring no child is left behind in the fight against cancer.
Background
Each year, more than 35,000 children and young people in Europe are diagnosed with cancer, and over 6,000 young patients lose their lives. Survivors often face long-term health challenges, and disparities in access to treatment across Europe lead to significant differences in survival rates, with Eastern European countries facing the most challenges. As rare oncological diseases, addressing the inequalities in paediatric cancers care requires sustained investment and strategic action on the EU level.